Australia's most trusted
source of pharma news
Saturday, 21 December 2024
Posted 2 October 2024 PM
As the compounding of semaglutide becomes illegal in Australia, counterfeit Ozempic pens have made their way into the country, the TGA has warned.
There has already been a life-threatening adverse event after a person used a counterfeit pen that was labelled as Ozempic, but which contained insulin instead. Unintended use of insulin can cause dangerously low life-threatening blood sugar levels.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.